Participant Safety
Cross-source consensus on Participant Safety from 1 sources and 5 claims.
1 sources · 5 claims
Risks & contraindications
Other
Other
Highlighted claims
- Consent is required before any trial-specific activity. — SHORTER trial: protocol for a pragmatic, multicentre, randomised controlled trial of short-duration antibiotic therapy for critically ill patients with sepsis
- Capacity is assessed and documented because critically ill patients may lack capacity. — SHORTER trial: protocol for a pragmatic, multicentre, randomised controlled trial of short-duration antibiotic therapy for critically ill patients with sepsis
- The key safety concern is undertreatment if 5 days of antibiotics is insufficient for some patients. — SHORTER trial: protocol for a pragmatic, multicentre, randomised controlled trial of short-duration antibiotic therapy for critically ill patients with sepsis
- The trial preserves clinical oversight so teams can prescribe additional antibiotics when clinically indicated. — SHORTER trial: protocol for a pragmatic, multicentre, randomised controlled trial of short-duration antibiotic therapy for critically ill patients with sepsis
- The trial reports adverse events considered associated with antibiotic use. — SHORTER trial: protocol for a pragmatic, multicentre, randomised controlled trial of short-duration antibiotic therapy for critically ill patients with sepsis